European equities traded in the US as American depositary receipts were treading water late Friday morning, edging 0.055% higher to 1,351.69 on the S&P Europe Select ADR Index, which has gained 1.4% for the week.
From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which rose 4.4% and 2.3% respectively. They were followed by 3D printer company Materialise (MTLS) and pharmaceutical company Novo Nordisk (NVO), which were up 1.9% and 1.7% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which fell 4% and 3.1% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and oil and gas company Eni (E), which were down 2.4% and 0.8% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group (MREO) and Bicycle Therapeutics (BCYC), which advanced 9.2% and 3% respectively. They were followed by software firm Endava (DAVA) and pharmaceutical company Silence Therapeutics (SLN), which increased by 4.1% and 2.5% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which dropped 10% and 1.5% respectively. They were followed by oil and gas companies BP (BP) and Shell (SHEL), which lost 1.4% and 1.3% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。